Literature DB >> 2860191

Purification and properties of human placental dipeptidyl peptidase IV.

S Mizutani, S Sumi, O Narita, Y Tomoda.   

Abstract

Dipeptidyl peptidase IV (EC 3.4.14.5; Gly-Pro-p-nitroanilidase) was purified 1840-fold from human placenta and characterized. The enzyme was solubilized from membrane fractions with Triton X-100 and subjected to zinc acetate fractionation, hydroxylapatite chromatography, Sephacryl S-300 chromatography and then affinity chromatographies with Lentil Lectin-Sepharose 4B and Gly-Pro-NH-(CH2)6-NH-Sepharose 4B. Dipeptidyl peptidase IV was completely separated from leucine aminopeptidase by the final affinity chromatography. The apparent molecular weight of the enzyme was estimated to be 350,000 by gel filtration. The purified enzyme gave a single band with a weight of 124,000 with sodium dodecyl sulfate (SDS) gel-electrophoresis, suggesting that the enzyme consists of three subunits. The isoelectric point of the enzyme was 4.4. The purified enzyme was most active at pH 8.0 with Gly-Pro-p-nitroanilide as substrate and the Km value for this substrate was 2.27mM.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2860191

Source DB:  PubMed          Journal:  Nihon Sanka Fujinka Gakkai Zasshi        ISSN: 0300-9165


  3 in total

Review 1.  Type 2 Diabetes Mellitus and Cancer: The Role of Pharmacotherapy.

Authors:  Gadi Shlomai; Brian Neel; Derek LeRoith; Emily Jane Gallagher
Journal:  J Clin Oncol       Date:  2016-11-07       Impact factor: 44.544

2.  Dipeptidyl peptidase 4 promotes epithelial cell transformation and breast tumourigenesis via induction of PIN1 gene expression.

Authors:  H J Choi; J Y Kim; S-C Lim; G Kim; H J Yun; H S Choi
Journal:  Br J Pharmacol       Date:  2015-10-16       Impact factor: 8.739

3.  In vivo imaging of phosphocreatine with artificial neural networks.

Authors:  Lin Chen; Michael Schär; Kannie W Y Chan; Jianpan Huang; Zhiliang Wei; Hanzhang Lu; Qin Qin; Robert G Weiss; Peter C M van Zijl; Jiadi Xu
Journal:  Nat Commun       Date:  2020-02-26       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.